The SUMO specific peptidase SENP3 promotes papillary thyroid cancer progression by deSUMOylation of SETDB1 and regulating GLI2 transcription [0.03%]
Zhe Wang,Ze Yang,Yong Chen et al.
Zhe Wang et al.
Haodong Zhang,Lei Xu,Yong Cui et al.
Haodong Zhang et al.
Hepatogenous diabetes in the era of precision medicine: diagnosis, management, and future directions [0.03%]
Gasser El-Azab,Mohamed Akl Rady,Medhat Assem et al.
Gasser El-Azab et al.
Hepatogenous diabetes (HD) is a distinct clinical entity that arises as a direct consequence of chronic liver disease, particularly cirrhosis. The complex interplay between hepatic dysfunction and glucose metabolism gives rise to unique pat...
Leukemia during pregnancy and survivorship: gestational age-stratified multidisciplinary management framework [0.03%]
Ning Zhang,Yin Jiang,Xilian Li et al.
Ning Zhang et al.
Identification of key programmed cell death genes-necroptosis-related genes in systemic lupus erythematosus [0.03%]
Lu Wang,Yuanyuan Li,Xinyi Liu et al.
Lu Wang et al.
Exploring the applicability, combined strategies, and challenges of ablation in hematology based on its characteristics and immunomodulatory mechanisms [0.03%]
基于消融的特点和免疫调节机制探讨其在血液病中应用的可行性、联合策略及挑战
Muyun Wu,Jiaqi Fu,Runjie Sun et al.
Muyun Wu et al.
A gene interaction network-based molecular taxonomy of dilated cardiomyopathy highlighting immune and inflammatory heterogeneity [0.03%]
基于基因互作网络的心肌病分子分型及其免疫和炎症异质性分析
Youyang Zheng,Fangfang Wan,Shulun Ma et al.
Youyang Zheng et al.
Bidirectional interplay between gut and liver in inflammatory bowel disease and hepatobiliary conditions [0.03%]
肠道和肝脏在炎症性肠病和胆道疾病中的相互作用
Ali Abdulla,Ayan M Sheikhnoor,Kevin Ferrao et al.
Ali Abdulla et al.
The neutrophil-percentage-to-albumin ratio (NPAR) shows a nonlinear correlation with all-cause mortality in patients with anemia [0.03%]
中性粒细胞百分比与贫血患者全因死亡率的非线性关联：血清白蛋白校正的作用
Anqi Peng,Jizhe Li,Jun Huang et al.
Anqi Peng et al.
A DLBCL Prognostic model superior to the IPI score: Mechanistic study and clinical validation based on RFC2- and RFC4-mediated DNA damage repair [0.03%]
基于RFC2和RFC4介导的DNA损伤修复的DLBCL预后模型优于IPI评分：机制研究与临床验证
Shuainan Wang,Yang Liu,Haoyu Zang et al.
Shuainan Wang et al.